title: Pro-inflammatory effect in mice of CvL, a lectin from the marine sponge Cliona varians.
abstract: CvL, a lectin from the marine sponge Cliona varians agglutinated type A papainized erythrocytes and was strongly inhibited by d-galactose and sucrose. Models of leukocyte migration in vivo were used to study the inflammatory activity of CvL through of mouse paw oedema and peritonitis. Effect of CvL on peritoneal macrophage activation was analysed. Effects of corticoids and NSAIDS drugs were also evaluated on peritonitis stimulated by CvL. Results showed that mouse hind-paw oedema induced by subplantar injections of CvL was dose dependent until 50 microg/cavity. This CvL dose when administered into mouse peritoneal cavities induced maxima cell migration (9283 cells/microL) at 24 h after injection. This effect was preferentially inhibited by incubation of CvL with the carbohydrates d-galactose followed by sucrose. Pre-treatment of mice with 3% thioglycolate increases the peritoneal macrophage population 2.3 times, and enhanced the neutrophil migration after 24 h CvL injection (75.8%, p<0.001) and no significant effect was observed in the presence of fMLP. Finally, pre-treatment of mice with dexamethasone (cytokine antagonist) decreased (65.6%, p<0.001), diclofenac (non-selective NSAID) decreased (34.5%, p<0.001) and Celecoxib (selective NSAID) had no effect on leukocyte migration after submission at peritonitis stimulated by CvL, respectively. Summarizing, data suggest that CvL shows pro-inflammatory activity, inducing neutrophil migration probably by pathway on resident macrophage activation and on chemotaxis mediated by cytokines.
authors.affiliation: Departamento de Biofísica e Farmacologia, Centro de Biociências, Universidade Federal do Rio Grande do Norte, Natal, RN, Brazil.
authors.forename: Alexandre F S
authors.initials: AF
authors.lastname: Queiroz
authors.forename: Raniere M
authors.initials: RM
authors.lastname: Moura
authors.forename: Jannison K C
authors.initials: JK
authors.lastname: Ribeiro
authors.forename: Ibson L
authors.initials: IL
authors.lastname: Lyra
authors.forename: Dayse C S
authors.initials: DC
authors.lastname: Cunha
authors.forename: Elizeu A
authors.initials: EA
authors.lastname: Santos
authors.forename: Maurício P
authors.initials: MP
authors.lastname: de-Sales
mesh_terms: D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology; D000068579:Celecoxib; D002634:Chemotaxis, Leukocyte / Q000187:drug effects*; D003907:Dexamethasone / Q000494:pharmacology; D004008:Diclofenac / Q000494:pharmacology; D004195:Disease Models, Animal; D004487:Edema / Q000139:chemically induced* / Q000503:physiopathology; D007249:Inflammation / Q000139:chemically induced* / Q000503:physiopathology; D037102:Lectins / Q000494:pharmacology*; D017737:Macrophages, Peritoneal / Q000187:drug effects / Q000276:immunology; D051379:Mice; D008815:Mice, Inbred Strains; D010538:Peritonitis / Q000139:chemically induced* / Q000503:physiopathology; D011161:Porifera / Q000737:chemistry*; D011720:Pyrazoles / Q000494:pharmacology; D013449:Sulfonamides / Q000494:pharmacology
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D037102:Lectins; D011720:Pyrazoles; D013449:Sulfonamides; D004008:Diclofenac; D003907:Dexamethasone; D000068579:Celecoxib